Cravatex Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 4,199.17 million compared to INR 4,397.19 million a year ago. Revenue was INR 4,262.55 million compared to INR 4,465.06 million a year ago. Net income was INR 550.96 million compared to net loss of INR 207.02 million a year ago. Basic earnings per share from continuing operations was INR 213.21 compared to basic loss per share from continuing operations of INR 80.12 a year ago. Diluted earnings per share from continuing operations was INR 213.21 compared to diluted loss per share from continuing operations of INR 80.12 a year ago.